ERAS
Erasca, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:59 PM EDT
14.73USD+1.029%(+0.15)3,837,106
Pre-marketOct 2, 2026 9:28:30 AM EDT
14.94USD+2.469%(+0.36)
After-hoursOct 2, 2026 4:07:30 PM EDT
14.70USD-0.204%(-0.03)
Loading…
Loading…
5.15B
Healthcare
Biotechnology
HQ
San Diego, CA, USA
129
Previous Close
$14.58
Beta
1.14
52-Week High
$24.28 2026-04-23
52-Week Low
$2.11 2025-11-07
SMA 50
$16.91
SMA 200
$13.98
Avg. Vol 10D
4.24M
Avg. Vol 30D
4.52M
Avg. Vol 90D
4.80M
Relative Vol
0.85
349.76M
222.52M
63.62%
33,036,139
14.85%
7.65
58%/42%
73.15%
57.27%
0.4100%
6,700,000
524
26,787
99,965
Nov 11, 2026 (37d)
Oct 1, 2026
These ten healthcare stocks posted the biggest one-month losses · 
Seeking Alpha
Sep 25, 2026
Notable Friday Option Activity: APP, ERAS, CRDO · 
BNK Invest
Sep 21, 2026
Sep 17, 2026
10 mid-cap healthcare stocks with the strongest momentum grades · Seeking Alpha
ERAS Profile
our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology's hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.
ERAS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 14.13 | 2026-09-28 | +4.26% | -1.037 |
| 1M | 16.19 | 2026-09-04 | -9.01% | 1.310 |
| 3M | 18.85 | 2026-07-06 | -21.85% | 1.766 |
| 6M | 17.12 | 2026-04-06 | -13.95% | 2.147 |
| 1Y | 2.42 | 2025-10-03 | +508.74% | 1.139 |
| 2Y | 2.54 | 2024-10-04 | +479.98% | — |
| 5Y | 22.13 | 2021-10-04 | -33.43% | 1.406 |
ERAS Stock Summary
Erasca, Inc. Common Stock (NASDAQ:ERAS) stock price today is $14.73, and today's volume is 3,837,106. ERAS is up 1.039% today. The 30 day average volume is 4.52M. ERAS market cap is $5.15B with 349.76M shares outstanding.